Long-Term Safety Performance of Fexofenadine in Asthma - Contacts and Locations

Home

Long-Term Safety Performance of Fexofenadine in Asthma

This study has been completed.

Study NCT00045955. Last updated on August 20, 2008. Information provided by Sanofi-Aventis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00045955

Locations


United States, New Jersey
	Aventis Pharmaceutical Inc.
	Bridgewater, New Jersey, United States, 08807

Sponsors and Collaborators

Sanofi-Aventis

Investigators


Study Director:	ICD CSD	Sanofi-Aventis